<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045259"><TermName>trimetrexate glucuronate</TermName><TermPronunciation>(TRY-meh-TREK-sayt gloo-KYOO-roh-nayt)</TermPronunciation><TermDefinition><DefinitionText>A drug that belongs to the family of drugs called antimetabolites. It is used in the treatment of pneumocystis carinii pneumonia and is being studied in the treatment of cancer.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000730848" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;trimetrexate glucuronate&quot;" language="en" id="_3"/><MediaLink ref="CDR0000730849" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;glucoronato de trimetrexato&quot;" language="es" id="_4"/><SpanishTermName>glucoronato de trimetrexato</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que es un tipo de antimetabolito. Se usa para tratar la neumonía por <ForeignWord>Pneumocystis carinii</ForeignWord> y está en estudio para el tratamiento del cáncer.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition></GlossaryTerm>
